CONVERGENCE PHARMACEUTICALS
Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The Company was formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (รขโฌลGSKรขโฌย). Convergence Pharmaceuticals has a pipeline of differentiated clinical-stage compounds targeting the points of convergence in chronic pain signaling through modulation of specific ion-channels.
CONVERGENCE PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Neuroscience
Founded:
2010-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.convergencepharma.com
Total Employee:
11+
Status:
Closed
Contact:
44 1223 755 501
Email Addresses:
[email protected]
Total Funding:
35.4 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Current Advisors List
Current Employees Featured
Founder
Investors List
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - Convergence Pharmaceuticals
SV Health Investors
SV Health Investors investment in Series A - Convergence Pharmaceuticals
Apposite Capital
Apposite Capital investment in Series A - Convergence Pharmaceuticals
Official Site Inspections
http://www.convergencepharma.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109